Physician profile
Michael Jon Thomas
NPI 1386872307
$15,570.76
in general payments reported to CMS, 2019-2025
10 companies · $777 in 2025
The $777 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $175 · 2021: $1,065 · 2022: $1,811 · 2023: $1,999 · 2024: $9,186 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $2,735 · Travel and Lodging: $2,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $2,735.35 |
| Travel and Lodging | $2,227.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,265.66 | 2019-2024 | |
| Atricure, INC. | $4,155.80 | 2019-2025 | Synergy Ablation System |
| Edwards Lifesciences Corporation | $1,315.38 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abiomed | $398.76 | 2022-2025 | Impella |
| La Jolla Pharmaceutical Company | $117.33 | 2025 | Giapreza |
| Zimmer Biomet Holdings, INC. | $105.12 | 2019-2021 | |
| Organogenesis INC. | $97.62 | 2022-2024 | Puraply |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.26 | 2019 | |
| Medical Device Business Services, INC. | $32.27 | 2023 | |
| Kls-Martin L.P. | $9.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.